A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China

BACKGROUND: There is no consensus regarding the risk stratification scores for elderly patients with diffuse large B-cell lymphoma (DLBCL). We aimed to compare the prognostic predictive ability of the current clinical scoring indices in DLBCL elderly patients treated with the R-CODP regimen (rituxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Hongye, Xu, Yanfeng, Liu, Yanfei, Mi, Lan, Wang, Xiaopei, Liu, Weiping, Zhu, Jun, Song, Yuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482890/
https://www.ncbi.nlm.nih.gov/pubmed/36133738
http://dx.doi.org/10.2147/CMAR.S359956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482890/
https://www.ncbi.nlm.nih.gov/pubmed/36133738
http://dx.doi.org/10.2147/CMAR.S359956

Ejemplares similares